换一批Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study.
第一作者：
Zachariah,DeFilipp
第一单位：
Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: zdefilipp@mgh.harvard.edu.
作者：
Zachariah,DeFilipp [1]
;
Richard,Ancheta [2]
;
Ying,Liu [3]
;
Zhen-Huan,Hu [4]
;
Robert Peter,Gale [5]
;
David,Snyder [6]
;
Harry C,Schouten [7]
;
Matt,Kalaycio [8]
;
Gerhard C,Hildebrandt [9]
;
Celalettin,Ustun [10]
;
Andrew,Daly [11]
;
Siddhartha,Ganguly [12]
;
Yoshihiro,Inamoto [13]
;
Mark,Litzow [14]
;
Jeffrey,Szer [15]
;
Mary Lynn,Savoie [11]
;
Nasheed,Hossain [16]
;
Mohamed A,Kharfan-Dabaja [17]
;
Mehdi,Hamadani [4]
;
Ran,Reshef [18]
;
Ashish,Bajel [15]
;
Kirk R,Schultz [19]
;
Shahinaz,Gadalla [20]
;
Aaron,Gerds [8]
;
Jane,Liesveld [21]
;
Mark B,Juckett [22]
;
Rammurti,Kamble [23]
;
Shahrukh,Hashmi [24]
;
Hisham,Abdel-Azim [25]
;
Melhem,Solh [26]
;
Ulrike,Bacher [27]
;
Hillard,Lazarus [28]
;
Richard,Olsson [29]
;
Jean-Yves,Cahn [30]
;
Michael R,Grunwald [31]
;
Bipin N,Savani [32]
;
Jean,Yared [33]
;
Jacob M,Rowe [34]
;
Jan,Cerny [35]
;
Naeem A,Chaudhri [36]
;
Mahmoud,Aljurf [36]
;
Amer,Beitinjaneh [37]
;
Sachiko,Seo [38]
;
Taiga,Nishihori [39]
;
Jack W,Hsu [40]
;
Muthalagu,Ramanathan [35]
;
Edwin,Alyea [41]
;
Uday,Popat [42]
;
Ronald,Sobecks [8]
;
Wael,Saber [4]
作者单位：
Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: zdefilipp@mgh.harvard.edu.
[1]
Scripps Blood & Marrow Transplant Program, Scripps Green Hospital, La Jolla, California.
[2]
Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, Wisconsin.
[3]
Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
[4]
Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom.
[5]
Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
[6]
Department of Hematology, Academische Ziekenhuis, Maastricht, The Netherlands.
[7]
Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
[8]
Markey Cancer Center, University of Kentucky, Lexington, Kentucky.
[9]
Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota.
[10]
Tom Baker Cancer Centre, Calgary, Alberta, Canada.
[11]
Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, Kansas.
[12]
Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
[13]
Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, Minnesota.
[14]
Department Clinical Haematology and Bone Marrow Transplantation, Royal Melbourne Hospital, Victoria, Australia.
[15]
Stanford Health Care, Stanford, California.
[16]
Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
[17]
Blood and Marrow Transplantation Program and Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York.
[18]
Department of Pediatric Hematology, Oncology and Bone Marrow Transplant, British Columbia's Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.
[19]
Division of Cancer Epidemiology & Genetics, NIH-NCI Clinical Genetics Branch, Rockville, Maryland.
[20]
Department of Medicine, University of Rochester Medical Center, Rochester, New York.
[21]
Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin.
[22]
Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.
[23]
Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota; Department of Oncology, Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
[24]
Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California.
[25]
The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, Georgia.
[26]
Department of Hematology, Inselspital, Bern University Hospital, Switzerland; Interdisciplinary Clinic for Stem Cell Transplantation, University Cancer Center Hamburg, Hamburg, Germany.
[27]
Seidman Cancer Center, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio.
[28]
Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.
[29]
Department of Hematology, CHU Grenoble Alpes, Grenoble, France.
[30]
Carolinas Medical Center Blumenthal Cancer Center Stem Cell Transplant Program, Levine Cancer Institute, Charlotte, North Carolina.
[31]
Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
[32]
Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland.
[33]
Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel.
[34]
Division of Hematology and Oncology, Department of Medicine, UMass Memorial Medical Center, Worcester, Massachusetts.
[35]
Department of Oncology, Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
[36]
Department of Medicine, University of Miami, Miami, Florida.
[37]
Department of Hematology & Oncology, National Cancer Research Center East, Chiba, Japan.
[38]
Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
[39]
Division of Hematology & Oncology, Department of Medicine, Shands HealthCare and University of Florida, Gainesville, Florida.
[40]
Center of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
[41]
Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
[42]
医学主题词
成年人(Adult);移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);白血病, 髓系, 慢性, BCR-ABL阳性(Leukemia, Myelogenous, Chronic, BCR-ABL Positive);蛋白激酶抑制剂(Protein Kinase Inhibitors)
DOI
10.1016/j.bbmt.2019.10.017
PMID
31669399
发布时间
2021-06-23
基金项目
U24 CA076518/CA/NCI NIH HHS/United States
- 浏览2
Biology of blood and marrow transplantation
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
